Eriko Sato

发表

Comparison of the effects of azole antifungal agents on the anticoagulant activity of warfarin.

I. Yano, K. Matsubara, S. Fukatsu, 2014, Biological & pharmaceutical bulletin.

Consequences of the JAK2V617F allele burden for the prediction of transformation into myelofibrosis from polycythemia vera and essential thrombocythemia

N. Komatsu, M. Koike, Marito Araki, 2015, International Journal of Hematology.

Prevalence of preexisting metabolic syndrome as defined by Japanese original criteria among patients with non-fatal myocardial infarction.

Shigeki Muto, Eriko Sato, R. Hamada, 2011, Internal medicine.

Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers

O. Ogawa, T. Kamoto, S. Masuda, 2007, International Journal of Clinical Oncology.

Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase

M. Kizaki, T. Nakazato, N. Komatsu, 2018, Medical Oncology.

Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group.

M. Kizaki, T. Nakazato, N. Komatsu, 2017, Leukemia research.

Evaluation of Calvert's formula for dosage adjustment of carboplatin in Japanese patients with hormone refractory prostate cancer.

H. Nishiyama, O. Ogawa, T. Kamoto, 2006, Biological & pharmaceutical bulletin.

The EUTOS long‐term survival score predicts disease‐specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice‐based cohort

M. Kizaki, T. Nakazato, N. Komatsu, 2020, Cancer medicine.

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia

J. Kanda, S. Kako, Y. Kanda, 2021, Blood advances.

Problems of primary T-cell lymphoma of the thyroid gland -A case report

N. Komatsu, J. Yokoyama, M. Fujimaki, 2012, World Journal of Surgical Oncology.

Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis

M. Kizaki, T. Nakazato, N. Komatsu, 2018, Medical Oncology.

Potential role for second‑generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: A retrospective CML Cooperative Study Group analysis.

M. Kizaki, T. Nakazato, N. Komatsu, 2019, Oncology reports.

Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) score

M. Kizaki, T. Nakazato, N. Komatsu, 2018, Leukemia & lymphoma.

NK-cell neoplasms in Japan

K. Kawa, K. Ohshima, R. Suzuki, 2005, Hematology.

Population Pharmacokinetics of Everolimus in Relation to Clinical Outcomes in Patients With Advanced Renal Cell Carcinoma

T. Yamasaki, O. Ogawa, S. Masuda, 2016, Therapeutic drug monitoring.

NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia

J. Kanda, S. Kako, Y. Kanda, 2022, International Journal of Hematology.

Effect of intestinal and hepatic first-pass extraction on the pharmacokinetics of everolimus in rats.

S. Masuda, I. Yano, K. Inui, 2008, Drug metabolism and pharmacokinetics.

Characteristics of CD5-positive splenic marginal zone lymphoma with leukemic manifestation ; clinical, flow cytometry, and histopathological findings of 11 cases.

K. Oshimi, K. Ando, N. Nakamura, 2010, Journal of clinical and experimental hematopathology : JCEH.

Vitamin B6 deficiency is prevalent in primary and secondary myelofibrosis patients

A. Gotoh, N. Komatsu, Masaru Tanaka, 2019, International Journal of Hematology.

Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.

N. Komatsu, Y. Ota, N. Aritaka, 2015, International journal of clinical and experimental pathology.

[Hemorrhagic colitis caused by dasatinib following cytomegalovirus enterocolitis in a patient with chronic myelogenous leukemia in the second chronic phase].

N. Komatsu, H. Yasuda, Yoshitaka Sunami, 2011, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Clinical Efficacy and Safety of First-Line Dasatinib Therapy and the Relevance of Velocity of BCR-ABL1 Transcript Decline for Achievement of Molecular Responses in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Report from the Juntendo Yamanashi Cooperative Study Group

J. Sakamoto, A. Gotoh, K. Kirito, 2017, Oncology.

Multiple brain infarctions induced by imatinib mesylate in a patient with clonal eosinophilia

K. Sugimoto, K. Oshimi, Y. Hamano, 2008, International journal of hematology.

Severe thrombocytopenia caused by littoral cell angioma

K. Sugimoto, B. Nobukawa, Eriko Sato, 2008, International journal of hematology.

Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors

M. Kizaki, T. Nakazato, N. Komatsu, 2022, Annals of medicine.

Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database

M. Kizaki, T. Nakazato, N. Komatsu, 2018, Annals of Hematology.

Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects

M. Kizaki, T. Nakazato, N. Iriyama, 2023, International Journal of Hematology.

Smoking influences the outcomes of patients receiving tyrosine kinase inhibitors for chronic myeloid leukemia in the chronic phase: A retrospective analysis

M. Kizaki, T. Nakazato, N. Komatsu, 2019, Hematological Oncology.

Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia

J. Kanda, S. Kako, Y. Kanda, 2023, Cancer science.

Temporal decline in sirolimus elimination immediately after pancreatic islet transplantation.

Hideo Nagata, Ikuko Yano, Teru Okitsu, 2006, Drug metabolism and pharmacokinetics.

18F‐Fluorodeoxyglucose positron emission tomography/computed tomography revealed the presence of simultaneous colon cancer in mucosa‐associated lymphoid tissue lymphoma

K. Sugimoto, N. Komatsu, Yoshitaka Sunami, 2011, Geriatrics & gerontology international.

Effectiveness of Everolimus in Combination with Cyclosporine as Treatment for Chronic Rejection in a Pediatric Patient Undergoing Liver Transplantation

S. Uemoto, S. Masuda, I. Yano, 2014 .

Larger dosage required for everolimus than sirolimus to maintain same blood concentration in two pancreatic islet transplant patients with tacrolimus.

S. Uemoto, S. Masuda, I. Yano, 2009, Drug metabolism and pharmacokinetics.

Successful treatment of extramedullary tumors with low-dose thalidomide in patients with multiple myeloma.

N. Komatsu, H. Yasuda, Naoko Inagaki, 2010, Internal medicine.

Vitamin B6 deficiency is prevalent in primary and secondary myelofibrosis patients

A. Gotoh, N. Komatsu, Masaru Tanaka, 2019, International Journal of Hematology.